Normal Suppressive T Cell Function of Epstein-Barr Virus Induced B Cell Activation in Type 1 (Insulin Dependent) Diabetes Mellitus

References

• Gupta S, Fikrig S M, Khanna S, Orti E. Deficiency of suppressor T-cells in insulin-dependent diabetes mellitus. An analysis with monoclonal antibodies. Immunol Lett 1982; 4: 289–94
   PubMed Web of Science ®Google Scholar
• Jackson R A, Morris M A, Haynes B F, Einsenbarth G S. Increased circulating la-antigen bearing T cells in type I diabetes mellitus. N Engl J Med 1982; 306: 785–88
   PubMed Web of Science ®Google Scholar
• Pontesilli O, Chase H P, Carotenuto P, Herberger M J, Hayward A R. T-lymphocytes subpopulations in insulin-dependent (type I) diabetes mellitus. Clin exp Immunol 1986; 63: 68–72
   PubMed Web of Science ®Google Scholar
• Mascart-Lemone F, Delespesse G, Dorchy H, Lemiere B, Servais G. Characterization of im-munoregulatory T lymphocytes in insulin-dependent diabetic children by means of monoclonal antibodies. Clin exp Immunol 1982; 41: 296–300
   Google Scholar
• Quiniou-Debrie M C, Debray-Sachs M, Dardenne M, Czernichow P, Assan R, Bach J F. Anti-islet cellular and humoral immunity, T-cell subsets, and thymic function in type I diabetes. Diabetes 1985; 34: 373–79
   PubMed Web of Science ®Google Scholar
• Crosti F, Secchi A, Ferrero E, Falqui L, Inverardi L, Pontiroli A E, et al. Impairment of lymphocyte-suppressive system in recent-onset insulin-dependent diabetes mellitus. Correlation with metabolic control. Diabetes 1986; 35: 1053–57
   PubMed Web of Science ®Google Scholar
• Pozzili P, Zuccarini O, Iavicoli M, Andreani D, Sensi M, Spencer K M, et al. Monoclonal antibodies defined abnormalities of T-lymphocytes in type I (insulin-dependent) diabetes. Diabetes 1983; 32: 91–94
   PubMed Web of Science ®Google Scholar
• Horita M, Suzuki H, Onodera T, Ginsberg-Fellner F, Fauci A S, Notkins A L. Abnormalities of immunoregulatory T cell subsets in patients with insulin-dependent diabetes mellitus. J Immunol 1982; 129: 1426–29
   PubMed Web of Science ®Google Scholar
• Alviggi L, Hoskins P J, Pyke D A, Johnston C, Tee D EH, Leslie R DG, Vegagni D. Pathogenesis of insulin-dependent diabetes: a role for activated T lymphocytes. Lancet 1984; 2: 4–6
   PubMed Web of Science ®Google Scholar
• Binimelis J, Oriola J, Codina M, Arill B, Carretero F, Perrez A, et al. T lymphocyte activation markers in newly diagnosed type 1 (insulin dependent) diabetic patients and in islet cell antibody-positive non diabetic siblings. Diabetologia 1987; 30: 47, Abstract
   PubMed Web of Science ®Google Scholar
• Hayward A R, Herberger M. Culture and phenotype of activated T cells from patients with type I diabetes mellitus. Diabetes 1984; 33: 319–23
   PubMed Web of Science ®Google Scholar
• Buschard K, Madsbad S, Rygaard J. Depressed suppressor cell activity in patients with newly diagnosed insulin-dependent diabetes mellitus. Clin exp Immunol 1980; 41: 25–32
   PubMed Web of Science ®Google Scholar
• Jaworski M A, Colle E, Guttmann R D. Abnormal immunoregulation in patients with insulin dependent diabetes mellitus and their healthy first degree relatives. Human Immunol 1983; 7: 25–34
   PubMed Web of Science ®Google Scholar
• Bird A G, Britton S. A new approach to the study of human B lymphocyte function using an indirect plaque assay and a direct B cell activator. Immunol Rev 1979; 45: 41–67
   PubMed Web of Science ®Google Scholar
• Tosato G, Magrath I T, Blaese R M. T-cell mediated immunoregulation of Epstein-Barr virus (EBV)-induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals. J Immunol 1982; 128: 575–79
   PubMed Web of Science ®Google Scholar
• Tosato G, Steinberg A D, Blaese R M. Defective EBV-specific suppressor T-cell function in rheumatoid arthritis. N Engl J Med 1981; 305: 1238–43
   PubMed Web of Science ®Google Scholar
• Depper J M, Bluestein H G, Zvaifler N J. Impaired regulation of Epstein-Barr virus induced lymphocyte proliferation in rheumatoid arthritis is due to a T cells defect. J Immunol 1981; 127: 1899–902
   PubMed Web of Science ®Google Scholar
• Kahan A., Kahan A, Amor B, Menkes C J. Different defects of T cell regulation of Epstein-Barr virus-induced B cell activation in rheumatoid arthritis. Arthritis Rheum 1985; 28: 961–70
   PubMedGoogle Scholar
• Kahan A, Kahan A, Menkes C J, Amor B. Defective Epstein-Barr virus specific suppressor T cell function in progressive systemic sclerosis. Ann Rheum Dis 1986; 45: 553–60
   PubMed Web of Science ®Google Scholar
• Tsokos G C, Magrath I T, Balow J E. Epstein-Barr virus induces normal B cell responses but defective suppressor T-cell responses in patients with systemic lupus erythematosus. J Immunol 1983; 131: 1797–801
   PubMed Web of Science ®Google Scholar
• Kahan A, LeFloch J P, Charreire J. Normal suppressive T cell function of Epstein-Barr virus induced B cell activation in Graves' disease. J Clin Endocrinol Metab 1987; 65: 555–60
   PubMed Web of Science ®Google Scholar
• Pellegrino M A, Ferrone S, Dietrich M P, Reisfeld R A. Enhancement of sheep red blood cell human lymphocyte rosette formation by sulfhydryl compound 2-amino-ethylisothiouronium bromide. Clin Immunol Immunopathol 1975; 3: 324–33
   PubMedGoogle Scholar
• Pujol-Borrell R, Todd I, Doshi M, Botazzo G F, Sutton R, Gray D, Adolf G R, Feldrnann M. HLA class II induction in human islet cells by interferon plus tumor necrosis factor or lymphotoxin. Name 1987; 326: 304–306
   Google Scholar
• Gupta S, Fikrig S, Orti E. Autologous mixed lymphocyte reaction in man VI. Deficiency of autologous mixed lymphocyte reaction in type I (insulin-dependent) diabetes mellitus. J Clin Lab Immunol 1983; 11: 59–62
   PubMedGoogle Scholar
• Fournier C, Chen H, Leger A, Charreire J. Immunological studies of autoimmune thyroid disorders: abnormalities in the inducer T cell subset and proliferative responses to autologous and allogenic stimulation. Clin exp Immunol 1987; 54: 539–46
   Google Scholar
• Chandy K G, Charles A M, Kershnar A, Buckingham B, Waldeck N, Gupta S. Autologous mixed lymphocyte reaction in man: XV. Cellular and molecular basis of deficient autologous mixed lymphocyte response in insulin-dependent diabetes mellitus. J Clin Imrnunol 1984; 4: 424–28
   Web of Science ®Google Scholar
• Nerup J, Andersen O O, Bendixen G, Egeverg J, Poulsen J E. Antipancreatic cellular hypersensitivity in diabetes mellitus. Diabetes 1971; 20: 424–27
   PubMed Web of Science ®Google Scholar
• Charles A M, Suzuki M, Waldeck N, Dodson L E, Slater L, Ong K, et al. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in human. J Immunol 1983; 130: 1189–94
   PubMed Web of Science ®Google Scholar
• Lohmann D, Krug J, Lampeter E F, Bierwolf B, Verlohren H J. Cell mediated immune reactions against B cells and defect of suppressor cell activity in type 1 (insulin dependent) diabetes mellitus. Diabetologia 1986; 29: 421–25
   PubMed Web of Science ®Google Scholar
• Boitard C, Debray-Sachs M, Pouplard A, Assan R, Hamburger J. Lymphocytes from diabetic suppress insulin release in vitro. Diabetologia 1981; 21: 41–46
   PubMed Web of Science ®Google Scholar
• Boitard C, Chatenoud L M, Debray-Sachs M. In vitro inhibition of pancreatic B cell function by lymphocytes from diabetics with associated autoimmune disease: a T cell phenomenon. J Immunol 1982; 129: 2529–31
   PubMed Web of Science ®Google Scholar
• Lohmann D, Lampeter E, Bierwolf B, Cossel L. Morphological studies on cell mediated beta cell damage. IDDM XII Congress of IDF. Diabetes Research and Clinical Practice. Elsevier. 1985; 887, suppl l (abstract)
   Google Scholar